What is the market doing?
What the tape says about COGT
Cogent Biosciences, Inc. is +191% over the past year while the S&P 500 is +20%: 171 points ahead of the market.
+191%
1-year return · S&P 500 +20%
- vs 200-day average
- −2.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 36
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-09-08
- $35.28
- 1 monthS&P 500 −0.30%
- −16%
- 1 yearS&P 500 +20%
- +191%
- 5 yearsS&P 500 +85%
- +339%
- vs 50-day average$37.23
- −5.2%
- 52-week high
- $42.84
- 52-week low
- $11.76
- Annualised volatility
- 103%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$370M
| Year | Return |
|---|---|
| 2026 (year to date) | −0.68% |
| 2025 | +355% |
| 2024 | +33% |
| 2023 | −49% |
| 2022 | +35% |
| 2021 | −24% |
| 2020 | +290% |
| 2019 | −84% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | −1.0% |
| Feb | 8 | 2 of 8 | −0.88% |
| Mar | 8 | 3 of 8 | −5.1% |
| Apr | 9 | 2 of 9 | −6.4% |
| May | 9 | 5 of 9 | +4.5% |
| Jun | 9 | 6 of 9 | +13% |
| Jul | 9 | 7 of 9 | +62% |
| Aug | 9 | 5 of 9 | +9.7% |
| Sep | 9 | 4 of 9 | −9.8% |
| Oct | 8 | 4 of 8 | −1.1% |
| Nov | 8 | 1 of 8 | +4.6% |
| Dec | 8 | 2 of 8 | −9.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.